化合物TCMDC-135051 T13102

Product Introduction
Bioactivity


英文名: TCMDC-135051

描述: TCMDC-135051 是一种高选择性和有效性的蛋白激酶 PfCLK3 抑制剂，具有低的靶外毒性。TCMDC-135051 可以防止滋养体到裂殖体的转变，破坏转录并减少向蚊子载体的传播。TCMDC-135051 具有抗寄生虫活性 (EC50=320 nM)。

体外活性: In a liver invasion and development assay, TCMDC-135051 shows potent activity against P. berghei sporozoites in which the compound shows a pEC50 value of 6.17 (EC50=0.40 μM). The kinase assays using recombinant PvCLK3 (P. vivax) and PbCLK3 (P. berghei) show that TCMDC-135051 has near-equipotent inhibition at these two orthologs, with pIC50 values of 7.47 (IC50=0.033 μM) and 7.86 (IC50=0.013 μM), respectively[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 225 mg/mL (477.1 mM)


关键字: TCMDC-135051 | TCMDC135051 | TCMDC 135051

相关库: Bioactive Compounds Library Max | Inhibitor Library | Anti-Parasitic Compound Library | Highly Selective Inhibitor Library | Bioactive Compound Library

化合物TCMDC-135051 T13102信息由TargetMol中国为您提供，如您想了解更多关于化合物TCMDC-135051 T13102报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途